好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Oxcarbazepine Extended-Release (SPN-804) Therapy in Patients with Refractory Partial Seizures: Review of Neurologic and Ophthalmologic Adverse Events
Epilepsy
(-)
107
Authors/Disclosures
Janet Johnson No disclosure on file
Scott Brittain (Supernus Pharmaceuticals, Inc.) No disclosure on file
No disclosure on file
No disclosure on file
Paolo Baroldi (Supernus Pharmaceuticals, Inc.) No disclosure on file
Bernd C. Kieseier, MD (Novartis) Dr. Kieseier has received personal compensation for serving as an employee of Novartis. Dr. Kieseier has stock in Novartis.